Site Members can sign up for company wide alerts
Investigation Overview
May 14, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) was announced concerning whether certain Progenics Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certain...
You must register (for free) or login to view the entire investigation.